Table 4 Multivariate analysis of prognostic factors, using corrected survival as an endpoint
From: Clinical significance of p27 Kip1 expression in advanced ovarian cancer
Variable | Grouping | P | Ratio of risk | 95% CI |
|---|---|---|---|---|
Response | CR, Micro dis., PR vs NR or progressive dis. | 0.013 | 1.05 | 0.45–1.42 |
Residual disease | < 2 cm vs > 2 cm | 0.0012 | 1.95 | 1.29–2.92 |
Grade | Well vs. moderate/poor | 0.0034 | 2.69 | 1.34–5.37 |
Pathology | Serous vs. non-serous | 0.043 | 1.42 | 0.99–2.04 |
Ascites | Present vs. absent | 0.048 | 1.47 | 1.01–2.16 |